ST榕泰(600589.SH):股东肖健拟减持不超2%股份
格隆汇11月15日丨ST榕泰(600589.SH)公布,截至本公吿披露日,公司股东肖健持有公司股份4603.65万股,合计占公司总股本比例为6.54%。
本减持计划自公吿披露之日起15个交易日后起180个自然日内通过证券交易所的集中竞价交易、大宗交易等法律法规允许的方式,减持本公司股份不超过1408.07万股,约占其所持股份的30.59%,约占公司总股本的比例的2%。
其中,以集中竞价交易方式减持的,在任意连续90个自然日内,减持股份的总数不超过公司股份总数的1%;以大宗交易方式减持的,在任意连续90个自然日内,减持股份的总数不超过公司股份总数的1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.